ASPIRE-MED: Psychotropic medicines training

This project addresses findings from the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (DRC) 2023 relating to the over-prescription of psychotropic medicines to people with intellectual disability.

The DRC 2023 made recommendations on the need for person-centred planning and resources, accessible information on psychotropic medicines for NDIS participants and health professionals, and better health information to enable informed decision-making.

This project aims to empower health professionals in relation to psychotropic medicines and people with intellectual disability by improving knowledge, skills, and advocacy through the development of a training program based on SPECTROM UK, adapted for the Australian healthcare context.

The project is funded by the Department of Health, Disability and Ageing.

See the project website: ASPIRE-MED

For further information on this, reach out to Dr Macey Barratt.